(EMAILWIRE.COM, June 09, 2008 ) Denver, CO - LegalView.com, the most comprehensive resource for everything and anything legal on the Web, informed its (http://mesothelioma.legalview.com/blog) mesothelioma information blog readers of a deadly contamination from asbestos on a Chicago beach. The Oak Street Beach, one of 33 beaches in the Chicago Park District frequented by visitors during the summer season, was the recent site of amphibole asbestos contamination. Individuals who may have been exposed to the asbestos fibers should seek medical attention immediately and, additionally, contact an experienced asbestos and mesothelioma law firm (http://mesothelioma.legalview.com/find-mesothelioma-law-firm.aspx).
Amphibole asbestos is considered the most harmful concentration of asbestos to humans because of the high levels of iron and its high resistance to heat and acids, according to the Canadian Centre for Occupational Health and Safety (CCOHS). Because of these qualities of resistance it was widely popular in industrial furnaces and heating system production. Exposure to asbestos causes a deadly form of cancer known as mesothelioma. This cancer remains dormant in many victims for years and when symptoms eventually begin to show, the cancer is often misdiagnosed with other conditions having similar symptoms. It is advisable that any individual currently suffering from the severity of this cancer, speak with a mesothelioma lawyer (http://mesothelioma.legalview.com/find-mesothelioma-lawer.aspx) who can provide insight into developing a lawsuit. Because treatment for mesothelioma is difficult and due to the fact that medical bills associated with this illness are often extremely expensive, seeking out an experienced attorney who can explain the details of any possible mesothelioma lawsuit (http://mesothelioma.legalview.com/mesothelioma-lawsuit-results.aspx) that might result in monetary compensation.
In addition to LegalView's mesothelioma and asbestos information portals, there are hundreds of other legal issues adversely affecting millions of Americans each year, which can be found at the LegalView library. LegalView continues to maintain its position as the best resource for everything legal on the Web and this is apparent through the continually updated legal portals such as the Digitek Digoxin portal, the Levaquin risks portal and the Chantix portal, which contains extensive amounts of information on the serious side effects associated with that prescription drug.
Digitek Digoxin is a prescription drug given to patients suffering from heart rhythm irregularities as well as other congestive heart failures. However, in April 2008, a MedWatch Safety Alert revealed that a Digitek recall (http://digitek-digoxin.legalview.com) needed to be enacted because of the potential for some of the drug's tablets to contain nearly twice the appropriate dosage of its active ingredient, which could be harmful to patients.
LegalView also recently displayed further developments on its Levaquin practice area after a scientific study linked the drug's use, which treats a range of bacterial infections, to a high risk of tendon rupture. Other Levaquin side effects (http://levaquin.legalview.com) can also include pain, inflammation and central nervous system damage.
Also updated recently is the Chantix information portal. Here, readers can find the latest information on the alleged risks associated with taking the drug as well as find out the potential for a Chantix recall(http://chantix.legalview.com).
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.
This press release was issued through GroupWeb EmailWire.Com. For more information on unlimited press release distribution service, go to http://www.emailwire.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: